Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Momentum Trap
197.9700 -8.55 (-4.14%)
NSE Oct 01, 2026 15:31 PM
Volume: 3.6M
 

logo
Piramal Pharma Ltd.
30 Jan 2026, 12:00AM
197.97
-4.14%
ICICI Direct
PPL owns 17 development and manufacturing facilities across India, US and UK with capabilities in sterile, API, formulations, drug discovery and manufacturing of nutrition products. The company holds 49% stake in AbbVie Therapeutics, JV with...
Piramal Pharma Ltd. has an average target of 238.33 from 3 brokers.
More from Piramal Pharma Ltd.
Recommended